Form 4: Inspire Medical Systems Director Exercises Options and Sells Shares Under 10b5-1 Plan

Director Jerry C. Griffin exercised stock options and sold shares of Inspire Medical Systems, Inc. under a pre-arranged 10b5-1 trading plan.

Summary

• On March 11, 2024, Jerry C. Griffin, a director of Inspire Medical Systems, Inc., exercised stock options to acquire 1,000 shares of common stock at a price of $16 per share.
• Following the exercise, Griffin sold 54 shares at $198.05 per share and 500 shares at $198.05 per share.
• These sales were executed under a 10b5-1 trading plan adopted on November 30, 2023.
• After these transactions, Griffin directly owns 9,744 shares of Inspire Medical Systems, Inc.
• He also holds options to purchase 2,296 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Insider transactions are common and closely monitored, especially those executed under 10b5-1 plans, which allow insiders to sell shares at predetermined times to avoid accusations of trading on non-public information.

Comparison to Industry Standards

• It's common for directors and officers of publicly traded companies to have stock option grants as part of their compensation packages.
• The use of 10b5-1 trading plans is a standard practice to allow insiders to diversify their holdings while avoiding potential insider trading concerns.
• Comparable companies in the medical device industry, such as Medtronic or Boston Scientific, also see regular Form 4 filings related to insider transactions.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the small number of shares involved.
• The sales could slightly increase the stock's float.

Key Dates